Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences
Introduction. Thrombotic complications (TC) in different vascular systems dictate the fate of high-risk patients. In cardiological practice, patients with advanced atherosclerotic vascular disease (MFA) represent the most vulnerable group. Malignant neoplasm (MN) is one of the most significant risk...
Saved in:
| Main Authors: | Yu. A. Fedotkina, A. L. Komarov, А. В. Dobrovolsky, E. N. Krivosheeva, О. О. Frolkova, E. V. Titaeva, T. V. Balakhonova, Е. Р. Panchenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«REMEDIUM GROUP» Ltd.
2023-01-01
|
| Series: | Атеротромбоз |
| Subjects: | |
| Online Access: | https://www.aterotromboz.ru/jour/article/view/287 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Growth differentiation factor 15 and the risk of cardiovascular events in patients with atrial fibrillation after elective percutaneous coronary intervention
by: E. N. Krivosheeva, et al.
Published: (2021-08-01) -
Assessment of the Anticancer Effects of Simvastatin on Human Osteosarcoma and Colorectal Cancer Cell Lines
by: Sarah Mazin Naeem, et al.
Published: (2024-12-01) -
Interrelation of growth/differentiation factor-15 level with laboratory and clinical and functional parameters of patients with coronary artery disease
by: E. A. Zakharyan
Published: (2023-06-01) -
Relationship between lipid profile parameters, coagulation system and inflammation markers in patients with hypertension and multifocal atherosclerosis
by: S. S. Vedenskaya, et al.
Published: (2024-12-01) -
Determinants of growth differentiation factor 15 plasma levels in outpatients with peripheral arterial disease
by: Emma Skau, et al.
Published: (2024-12-01)